Lyso-Monosialoganglioside GM2 (ammonium salt) (Synonyms: Lysoganglioside GM2, Lyso-GM2, lyso-Monosialoganglioside GM2) |
| Catalog No.GC48345 |
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Lyso-monosialoganglioside GM2 (Lyso-GM2) is a form of ganglioside GM2 that is lacking the fatty acyl group. Lyso-GM2 inhibits PKC in a cell-free assay (IC50 = 50 µM).1 Levels of lyso-GM2 are increased in the gray matter of postmortem brain samples from patients with Sandhoff disease or Tay-Sachs disease, as well as in a mouse model of Sandhoff disease.2,3 [Matreya, LLC. Catalog No. 1543]
1.Hannun, Y.A., and Bell, R.M.Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidosesScience235(4789)670-674(1987) 2.Kobayashi, T., Goto, I., Okada, S., et al.Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidosesJ. Neurochem.59(4)1452-1458(1992) 3.Kodama, T., Togawa, T., Tsukimura, T., et al.Lyso-GM2 ganglioside: A possible biomarker of Tay-Sachs disease and Sandhoff diseasePLoS One6(12)e29074(2011)
Average Rating: 5 (Based on Reviews and 16 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *